cardiovascular system
• exhibit neutral lipid droplet accumulation in cardiac myocytes after a short-term fast
• myocardial triacylglycerol levels are higher in fasted mutants than in controls, specifically long-chain fatty acid-containing triacylglycerol
• myocyte hypertrophy seen in 3-month old mutants
|
• exhibit an increase in biventricular weight/body weight ratio
|
• mean rate of [3H]palmitate oxidation is 64% higher in isolated hearts, indicating increased fatty acid utilization
• mean glucose oxidation rates are diminished by 63% in hearts, indicating decreased glucose utilization
|
• the posterior wall thickness is increased and fractional shortening is reduced
|
• exhibit signatures of diabetic cardiomyopathy including ventricular hypertrophy, activation of gene markers of pathologic hypertrophic growth, and alteration systolic ventricular function
|
homeostasis/metabolism
• exhibit neutral lipid droplet accumulation in cardiac myocytes after a short-term fast
|
• myocardial triacylglycerol levels are higher in fasted mutants than in controls, specifically long-chain fatty acid-containing triacylglycerol
|
muscle
• exhibit neutral lipid droplet accumulation in cardiac myocytes after a short-term fast
• myocardial triacylglycerol levels are higher in fasted mutants than in controls, specifically long-chain fatty acid-containing triacylglycerol
• myocyte hypertrophy seen in 3-month old mutants
|
• the posterior wall thickness is increased and fractional shortening is reduced
|
• exhibit signatures of diabetic cardiomyopathy including ventricular hypertrophy, activation of gene markers of pathologic hypertrophic growth, and alteration systolic ventricular function
|
growth/size/body
• exhibit an increase in biventricular weight/body weight ratio
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
diabetes mellitus | DOID:9351 | J:110580 |